» Articles » PMID: 35322553

Long Non-coding RNA H19 Promotes Leukocyte Inflammation in Ischemic Stroke by Targeting the MiR-29b/C1QTNF6 Axis

Overview
Specialties Neurology
Pharmacology
Date 2022 Mar 24
PMID 35322553
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Inflammatory processes induced by leukocytes are crucially involved in the pathophysiology of acute ischemic stroke. This study aimed to elucidate the inflammatory mechanism of long non-coding RNA (lncRNA) H19-mediated regulation of C1q and tumor necrosis factor 6 (C1QTNF6) by sponging miR-29b in leukocytes during ischemic stroke.

Methods: H19 and miR-29b expression in leukocytes of patients with ischemic stroke and rats with middle cerebral artery occlusion were measured by real-time polymerase chain reaction. H19 siRNA and miR-29b antagomir were used to knock down H19 and miR-29b, respectively. We performed in vivo and in vitro experiments to determine the impact of H19 and miR-29b on C1QTNF6 expression in leukocytes after ischemic injury.

Results: H19 and C1QTNF6 upregulation, as well as miR-29b downregulation, was detected in leukocytes of patients with stroke. Moreover, miR-29b could bind C1QTNF6 mRNA and repress its expression, while H19 could sponge miR-29b to maintain C1QTNF6 expression. C1QTNF6 overexpression promoted the release of IL-1β and TNF-α in leukocytes, further exacerbated blood-brain barrier disruption, and aggravated the cerebral ischemic injury.

Conclusions: Our findings confirm that H19 promotes leukocyte inflammation by targeting the miR-29b/C1QTNF6 axis in cerebral ischemic injury.

Citing Articles

LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review.

Esmaeili A, Yazdanpanah N, Rezaei N Cell Mol Neurobiol. 2025; 45(1):21.

PMID: 40056236 PMC: 11890384. DOI: 10.1007/s10571-025-01538-0.


Hypoxic Postconditioning Offers Neuroprotection Against Transient Cerebral Ischemia via Down-Regulation of rno_piR_011022.

Chen M, Duan S, Chai G, Zhan L, Peng L, Sun W CNS Neurosci Ther. 2025; 31(2):e70295.

PMID: 39996480 PMC: 11851155. DOI: 10.1111/cns.70295.


Epigenetic regulation of the inflammatory response in stroke.

Liang J, Yang F, Li Z, Li Q Neural Regen Res. 2024; 20(11):3045-3062.

PMID: 39589183 PMC: 11881735. DOI: 10.4103/NRR.NRR-D-24-00672.


The role of ACSL4 in stroke: mechanisms and potential therapeutic target.

Zhuo B, Qin C, Deng S, Jiang H, Si S, Tao F Mol Cell Biochem. 2024; .

PMID: 39496916 DOI: 10.1007/s11010-024-05150-6.


Long Non-Coding H19 in Lymphocytes: Prognostic Value in Acute Ischemic Stroke Patients.

Zhong L, Xie Z, Han Z, Fan J, Wang R, Tao Z Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204113 PMC: 11357374. DOI: 10.3390/ph17081008.


References
1.
Ding R, Hase Y, Ameen-Ali K, Ndungu M, Stevenson W, Barsby J . Loss of capillary pericytes and the blood-brain barrier in white matter in poststroke and vascular dementias and Alzheimer's disease. Brain Pathol. 2020; 30(6):1087-1101. PMC: 8018063. DOI: 10.1111/bpa.12888. View

2.
Wang J, Zhao H, Fan Z, Li G, Ma Q, Tao Z . Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization. Stroke. 2017; 48(8):2211-2221. DOI: 10.1161/STROKEAHA.117.017387. View

3.
Kim M, Lee W, Park E, Park S . C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages. Mol Cells. 2010; 30(1):59-64. DOI: 10.1007/s10059-010-0088-x. View

4.
Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

5.
Mendelson S, Prabhakaran S . Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021; 325(11):1088-1098. DOI: 10.1001/jama.2020.26867. View